Structural
Aortic Valve Disease Learning Series
Aortic Stenosis - General Concepts
Episodes
Interventional literature review
10 min.
Will Early Valve Performance Affect Late Outcomes in Small Annuli? Maybe It Won't
14 min.
Cardiac Manifestations of Aortic Stenosis in Women: It is Not Just The Annular Size?
15 min.
What Is A Small Annulus? It Depends Upon Where You Live!
11 min.
Unique Associations with A Small Annulus (SOVs, Coronary Heights, LVOT Calcium): Does This Affect Decision Making For Lifetime Management?
13 min.
Treatment Algorithms for Acute Decompensated Valvular Heart Disease
8 min.
Small Annulus Definitions, Misconceptions, and the Great Divide
17 min.
Where is the Evidence that Watchful Waiting should be the Preferred Strategy for Aortic Stenosis?
10 min.
AVR in Asymptomatic Severe Aortic Stenosis: The EARLY TAVR Trial and Beyond
10 min.
TAVR Across the Age Spectrum
9 min.
What Is the Evidence for Clinical Surveillance in Severe Aortic Stenosis?
11 min.
Clinical and Economic Outcomes by Stage of Cardiac Damage and Clinical Presentation at Aortic Valve Replacemen
13 min.
Structural Valve Dysfunction: Overview of Definitions
12 min.
Low Flow Low Gradient Severe Aortic Stenosis: How Low Is Too Low To Treat?
12 min.
Is There Hope for Medical Management of Aortic Stenosis? New Potential Therapies for Prevention and Treatment
13 min.
Cardiac Damage and Its Impact on Timing of TAVR
9 min.
Addressing Undertreatment And Disparities In Valvular Heart Disease: Have We Made Progress?
13 min.
Managing AS Patients Before Symptoms or Severe Disease: Insights Into Current Practice
0
Structural Keynote Lecture: Essentials of Lifetime Management of Aortic Disease in 2023
17 min.
Does Mild PVL Really Matter and What Can Be Done About It?
14 min.
When Do I Really Need a Cardiac Catheterization in Anticipation of TAVR?
13 min.
Minimalist TAVR And What It Means for Procedural Optimization in 2023
12 min.
Where It All Begins: Valve Clinic and the Multidisciplinary Heart Team
8 min.
Prophylactic Antithrombotic Therapy After TAVR
12 min.
Clinical Valve Thrombosis: Diagnosis, Management, and Prognosis
14 min.
A Challenging Case of Clinical Valve Thrombosis
3 min.
Defining Valve Thrombosis: Making Sense of Alphabet Soup
5 min.
I Have a Crystal Ball: What Will the AVR Universe Look Like in 2030?
9 min.
Technical Considerations for Index TAVR in a Younger Patient
15 min.
Position 2: Initial SAVR With Bioprosthetic Valve/Ross
5 min.
Lifetime Management of AS: What Do the Patients Want?
15 min.
Case Presentation: 59-Year-Old Male With Trileaflet Aortic Valve Stenosis
4 min.
Position 1: Initial SAVR With Mechanical Valve
6 min.
Position 3: Initial TAVR
16 min.
Perspective: How I See the Future for TAVR in Younger Patients With Bicuspid AS
7 min.
We Need an RCT, and Here Is How I Would Like to Design It
7 min.
Case Resolution: A Patient <65 Years Old With Severe Symptomatic Bicuspid Aortic Stenosis With Favorable TAVR Anatomy
2 min.
Index SAVR in Young Patients With Bicuspid AS Is Better for Lifetime Management
10 min.
Moderate AS in HFrEF: Time to Treat Is Now
15 min.
Pharmacotherapy to Slow AS Progression and Protect the Heart
9 min.
EARLY TAVR
5 min.
Moderate AS With Heart Failure: TAVR UNLOAD
4 min.
Moderate AS With Cardiac Damage: The PROGRESS Trial
5 min.
Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial
8 min.
EVOLVED: CMR As an Early Marker of Risk
6 min.
Staging of Aortic Stenosis According to Cardiac Dysfunction
7 min.
Imaging-Derived New Phenotypes of AS Severity
7 min.
Updates on ECG-Based Algorithms
5 min.
“Access to Care” Issues in Aortic Stenosis Patients
10 min.
UPSTREAM Aortic Stenosis Management: Conceptual Framework
6 min.
SAVR in Severe Aortic Stenosis With Small Aortic Annulus: What Are the Options?
11 min.
The Case For TAVR in Severe Aortic Stenosis With Small Aortic Annulus
7 min.
Discordant Echocardiographic and Invasive Hemodynamics in Aortic Stenosis: When Does It Matter?
16 min.
TAVR vs SAVR in Low Gradient AS: Evidence Updates
18 min.
Diagnosing Low Gradient Aortic Stenosis: Time to Get It Right
16 min.
Multi-Valve and Concomitant Cardiovascular Disease: Gaps in the Guidelines
17 min.
Keynote: Structural Transcatheter Innovation from China: Highlights of New Valve Therapies Which Will Impact Clinical Practice
20 min.
High Surgical Risk Aortic Regurgitation: New TAVR Alternatives
11 min.
Moderate AS With Heart Failure: UNLOAD and Beyond
9 min.
Managing Heart Failure in AS With Multivalve Disease
10 min.
Low Flow - Low Gradient AS and Assessing Myocardial Reserve
15 min.
Recurrent Heart Failure After AVR: Causes and Treatment
8 min.
AS Reclassified According to Valve Function and Cardiac Disease
11 min.
Intro to Session
8 min.
Why Long-Term Valve Performance Matter
11 min.
Lifetime Management of Aortic Stenosis: The Importance of Choosing the First Valve
16 min.
Position 3: TAVR With a Supra-Annular Valve
6 min.
Moderate AS With ‘At Risk Features: The EXPAND TAVR II Trial
9 min.
Case-Based Approach to Patients With Severe AS and MR (Degenerative and Functional)
11 min.
Considerations for Physiologic Testing to Assess CAD Severity in Patients With AS
8 min.
Position 2: TAVR With an Annular Valve
7 min.
Position 1: SAVR With Root Enlargement
10 min.
Moderate AS With ‘At Risk’ Features: The PROGRESS Trial
5 min.
SPOTLIGHT LECTURE Staging of Aortic Stenosis According to Cardiac Dysfunction: Recent Updates
17 min.
UPSTREAM Aortic Stenosis Management: Conceptual Framework
9 min.
How Do We Communicate Known vs Uncertain Risks and Benefits of TAVR to Younger (<65 yo) Patients?
14 min.
Minimalist TAVR in 2023: Practical Tips and Tricks for a Safer, Less Invasive Procedure
16 min.
TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples
11 min.
TAVR With the Balloon-Expandable SAPIEN 3 Ultra: Procedural Techniques With Case Examples
9 min.
Bioskills: Understanding the Aortic Valve Anatomy and the Iteration with TAVR Devices
32 min.
Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?
8 min.
A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis : How Will Emerging Evidence Help Us?
3 min.
A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis: What Do the Guidelines Say?
4 min.
Patient Prosthesis Mismatch After TAVR – Does Valve Selection Matter in the Small Annulus?
8 min.
Management of Concomitant Coronary Disease in AVR-Eligible Patients – COMPLEAT or NOT?
9 min.
Cerebral Embolic Protection: Why, When, and Who?
7 min.
Expanding TAVR to Moderate Aortic Stenosis: The Next Frontier?
7 min.
Optimal Anti-Thrombotic Therapy After TAVR – Updates and Controversies
10 min.
The Importance of Pre-emptive TAVR in the Future Management of Aortic Stenosis
13 min.
PENDING - CT-Guided ADR in a Calcium-Free LAD CTO Segment in a Post-TAVI/Post-CABG Patient
6 min.